Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequency Distributions of Alleles and Genotypes and Lung Cancer Risk of Polymorphisms DCK, SLC29A1, and SLC29A3 in South Indian Healthy Population. | Cureus | 2024 | 39564037 | PubTator, text mining | PubMed |
| Targeting splicing for hematological malignancies therapy. | BMC Genomics | 2024 | 39528914 | PubTator, text mining | PubMed |
| A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation. | Sci Rep | 2024 | 39472491 | PubTator, text mining | PubMed |
| Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience. | J Med Biochem | 2024 | 39139169 | PubTator, text mining | PubMed |
| Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic? | Neurotherapeutics | 2024 | 38937160 | PubTator, text mining | PubMed |
| The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism. | Cell Oncol (Dordr) | 2024 | 38888850 | PubTator, text mining | PubMed |
| In vitro evolution and whole genome analysis to study chemotherapy drug resistance in haploid human cells. | Sci Rep | 2024 | 38886371 | PubTator, text mining | PubMed |
| The DNA Methyltransferase Inhibitor 5-Aza-4'-thio-2'-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia Development. | Cancer Res | 2024 | 38832931 | PubTator, text mining | PubMed |
| Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. | Cell Death Dis | 2024 | 38821944 | PubTator, text mining | PubMed |
| Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection. | Breast Cancer Res | 2024 | 38745208 | PubTator, text mining | PubMed |
| Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing. | Neoplasia | 2024 | 38744194 | PubTator, text mining | PubMed |
| Vocabulary Matters: An Annotation Pipeline and Four Deep Learning Algorithms for Enzyme Named Entity Recognition. | J Proteome Res | 2024 | 38733346 | PubTator, text mining | PubMed |
| Butterfly Effect in Cytarabine: Combined NMR-NQR Experiment, Solid-State Computational Modeling, Quantitative Structure-Property Relationships and Molecular Docking Study. | Pharmaceuticals (Basel) | 2024 | 38675407 | PubTator, text mining | PubMed |
| Antitumoral activity of different Amaryllidaceae alkaloids: In vitro and in silico assays. | J Ethnopharmacol | 2024 | 38614259 | PubTator, text mining | PubMed |
| A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses. | Aging (Albany NY) | 2024 | 38517376 | PubTator, text mining | PubMed |
| Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation. | Elife | 2024 | 38512723 | PubTator, text mining | PubMed |
| Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. | Cell Death Dis | 2024 | 38346958 | PubTator, text mining | PubMed |
| Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniques. | MethodsX | 2024 | 38299040 | PubTator, text mining | PubMed |
| Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. | Biomedicines | 2024 | 38275398 | PubTator, text mining | PubMed |
| TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress. | Mol Biol Rep | 2024 | 38270700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=3